Profile
Joern-Peter Halle is currently a Venture Partner at Biogeneration Management BV since 2024.
Formerly, the role of Chief Strategy Officer was held at Merck KGaA from 2022 to 2024.
The position of Director was held at iOnctura SA. Education includes a doctorate from Universität Konstanz conferred in 1994.
Joern-Peter Halle active positions
| Companies | Position | Start |
|---|---|---|
Biogeneration Management BV
Biogeneration Management BV Investment ManagersFinance Biogeneration Management invests in companies located in the United States, Netherlands and Europe. The firm targets companies operating in the fields of biotechnology sectors. It provides financing for pre-seed, seed and early stage capital requirements. It also acts as lead investor. | Private Equity Investor | 2024-03-31 |
Former positions of Joern-Peter Halle
| Companies | Position | End |
|---|---|---|
| MERCK KGAA | Corporate Officer/Principal | 2024-02-29 |
iOnctura SA
iOnctura SA BiotechnologyHealth Technology Develops therapies that extend health span for cancer patients | Director/Board Member | - |
Training of Joern-Peter Halle
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Merck KGaA
Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Universität Konstanz
Universität Konstanz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogeneration Management BV
Biogeneration Management BV Investment ManagersFinance Biogeneration Management invests in companies located in the United States, Netherlands and Europe. The firm targets companies operating in the fields of biotechnology sectors. It provides financing for pre-seed, seed and early stage capital requirements. It also acts as lead investor. | Finance |
iOnctura SA
iOnctura SA BiotechnologyHealth Technology Develops therapies that extend health span for cancer patients | Health Technology |
- Stock Market
- Insiders
- Joern-Peter Halle
















